FDA withdraws proposed rule that would have banned minors from using tanning beds

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

Boca Raton resident Gabriela Sanchez recently found herself stepping into a mobile outreach vehicle operated by Sylvester Comprehensive Cancer Center.

April 17, 2026

Vol.52 No.15

By Claire Marie Porter

Cancer Policy

FDA adds stereotactic breast biopsy needles to the shortage list

FDA has added stereotactic breast biopsy needles to its Medical Device Shortages List with an estimated duration of “through Q4 2026,” which spans July 1 to Sept. 30.

FDA issues reminder to sponsors: Disclose clinical trial results

FDA issued a stern reminder to medical product companies and researchers of the requirements to submit certain clinical trial results information to ClinicalTrials.gov.

Destination Healthy Skin RV will provide free skin exams in 40 U.S. cities

The Skin Cancer Foundation is bringing Destination Healthy Skin to 40 cities in 22 states this year. The Foundation kicked off its 2026 mobile education and screening program on April 15 in Columbus, Ohio.

April 17, 2026

Vol.52 No.15

Drugs & Targets

FDA clears first HPV self-collection kit and assay for at-home use, marking a step toward improving screening uptake

FDA cleared Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay with extended genotyping for at-home use, marking a significant milestone in expanding access to cervical cancer screening and removing barriers that currently prevent many individuals from receiving routine screening.

April 10, 2026

Vol.52 No.14

Drugs & Targets

Nuvalent submits NDA to FDA for neladalkib in TKI pre-treated advanced ALK-positive NSCLC

Nuvalent announced the submission of a New Drug Application to FDA for neladalkib, an investigational ALK-selective inhibitor, in TKI pre-treated advanced ALK-positive non-small cell lung cancer.

April 10, 2026

Vol.52 No.14

FDA withdraws proposed rule that would have banned minors from using tanning beds

YOU MAY BE INTERESTED IN

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

FDA adds stereotactic breast biopsy needles to the shortage list

FDA issues reminder to sponsors: Disclose clinical trial results

Destination Healthy Skin RV will provide free skin exams in 40 U.S. cities

FDA clears first HPV self-collection kit and assay for at-home use, marking a step toward improving screening uptake

Nuvalent submits NDA to FDA for neladalkib in TKI pre-treated advanced ALK-positive NSCLC

Renew today!

Subscriber content

Never miss an issue!

Login

FDA withdraws proposed rule that would have banned minors from using tanning beds

YOU MAY BE INTERESTED IN

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancerA kit for at-home unsupervised self-collection clears FDA finish line

FDA adds stereotactic breast biopsy needles to the shortage list

FDA issues reminder to sponsors: Disclose clinical trial results

Destination Healthy Skin RV will provide free skin exams in 40 U.S. cities

FDA clears first HPV self-collection kit and assay for at-home use, marking a step toward improving screening uptake

Nuvalent submits NDA to FDA for neladalkib in TKI pre-treated advanced ALK-positive NSCLC

Never miss an issue!

Login

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

Destination Healthy Skin RV will provide free skin exams in 40 U.S. cities